A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis-Reference-Cited by-同舟云学术

A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis

Published:2020-11 Issue:5 Volume:32 Page:878-888.e6
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Oh Tae Gyu,Kim Susy M.,Caussy Cyrielle,Fu Ting,Guo Jian,Bassirian Shirin,Singh Seema,Madamba Egbert V.,Bettencourt Ricki,Richards Lisa,Yu Ruth T.,Atkins Annette R.,Huan Tao,Brenner David A.,Sirlin Claude B.,Downes Michael,Evans Ronald M.,Loomba Rohit

Funder

National Heart, Lung, and Blood Institute

National Institute of Environmental Health Sciences

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference45 articles.

1. Altered microbiome in patients with cirrhosis and complications;Acharya;Clin. Gastroenterol. Hepatol.,2019

2. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis;Caussy;Hepatology,2018

3. Collagen formation assessed by N-terminal propeptide of type 3 procollagen is a heritable trait and is associated with liver fibrosis assessed by magnetic resonance elastography;Caussy;Hepatology,2019

4. Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD;Caussy;Hepatology,2018

5. Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis;Caussy;J. Clin. Invest.,2017

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine;The Journal of Nutritional Biochemistry;2024-11

2. Protection against fibrosis by a bacterial consortium in metabolic dysfunction-associated steatohepatitis and the role of amino acid metabolism;Gut Microbes;2024-09-06

3. Artificial intelligence in metabolomics: a current review;TrAC Trends in Analytical Chemistry;2024-09

4. Artificial intelligence applied to ‘omics data in liver disease: towards a personalised approach for diagnosis, prognosis and treatment;Gut;2024-08-22

5. The signatures and crosstalk of gut microbiome, mycobiome, and metabolites in decompensated cirrhotic patients;Frontiers in Microbiology;2024-08-21